Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding
Gespeichert in:
| Veröffentlicht in: | The Journal of heart and lung transplantation 2020-05, Vol.39 (5), p.492-495 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 495 |
|---|---|
| container_issue | 5 |
| container_start_page | 492 |
| container_title | The Journal of heart and lung transplantation |
| container_volume | 39 |
| creator | Asleh, Rabea Albitar, Hasan Ahmad Hasan Schettle, Sarah D. Kushwaha, Sudhir S. Pereira, Naveen L. Behfar, Atta Stulak, John M. Rodeheffer, Richard J. Iyer, Vivek N. |
| description | |
| doi_str_mv | 10.1016/j.healun.2020.02.012 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2377684665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053249820314066</els_id><sourcerecordid>2377684665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-9f31b94f746e5a7b88fb4f0370f64f035b810de5ad8b3764c343ec81c68da2e33</originalsourceid><addsrcrecordid>eNp9kEuLFTEQhYMozjj6D0SydNNtHt1J340gg4-BATe6DpV0ZcwlnR6TdMOIP95c7ujSRahAnVNV5yPkNWc9Z1y9O_Y_EOKWesEE65noGRdPyCUfR91JzvXT9mej7MRwmC7Ii1KOjDEhR_GcXEjB9eldkt83qWbYMa1boRZ3cOHXtoClUCjQtO4Yac0IdcFUqV8zzegzuLrmBxrRV9q8NQe3RcjNVEKpdMY9OOwyRqg40zsoNa8hVSw1JIjURsQ5pLuX5JmHWPDVY70i3z99_Hb9pbv9-vnm-sNt56QStTt4ye1h8HpQOIK20-Tt4JnUzKtTHe3E2dxa82SlVoOTg0Q3caemGQRKeUXenufe5_Xn1q4wSygOY4SELbcRUms1DUqNTTqcpS6vpbSs5j6HBfKD4cycuJujOXM3J-6GCdO4N9ubxw2bXXD-Z_oLugnenwXYcu4BsykuYHKNQ0ZXzbyG_2_4A_SZmS4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2377684665</pqid></control><display><type>article</type><title>Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Asleh, Rabea ; Albitar, Hasan Ahmad Hasan ; Schettle, Sarah D. ; Kushwaha, Sudhir S. ; Pereira, Naveen L. ; Behfar, Atta ; Stulak, John M. ; Rodeheffer, Richard J. ; Iyer, Vivek N.</creator><creatorcontrib>Asleh, Rabea ; Albitar, Hasan Ahmad Hasan ; Schettle, Sarah D. ; Kushwaha, Sudhir S. ; Pereira, Naveen L. ; Behfar, Atta ; Stulak, John M. ; Rodeheffer, Richard J. ; Iyer, Vivek N.</creatorcontrib><identifier>ISSN: 1053-2498</identifier><identifier>EISSN: 1557-3117</identifier><identifier>DOI: 10.1016/j.healun.2020.02.012</identifier><identifier>PMID: 32173217</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Intravenous ; Aged ; Angiogenesis Inhibitors - administration & dosage ; Bevacizumab - administration & dosage ; Female ; Follow-Up Studies ; Gastrointestinal Hemorrhage - drug therapy ; Gastrointestinal Hemorrhage - etiology ; Heart Failure - therapy ; Heart-Assist Devices - adverse effects ; Humans ; Male ; Retrospective Studies ; Treatment Outcome</subject><ispartof>The Journal of heart and lung transplantation, 2020-05, Vol.39 (5), p.492-495</ispartof><rights>2020 International Society for Heart and Lung Transplantation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-9f31b94f746e5a7b88fb4f0370f64f035b810de5ad8b3764c343ec81c68da2e33</citedby><cites>FETCH-LOGICAL-c362t-9f31b94f746e5a7b88fb4f0370f64f035b810de5ad8b3764c343ec81c68da2e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1053249820314066$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32173217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asleh, Rabea</creatorcontrib><creatorcontrib>Albitar, Hasan Ahmad Hasan</creatorcontrib><creatorcontrib>Schettle, Sarah D.</creatorcontrib><creatorcontrib>Kushwaha, Sudhir S.</creatorcontrib><creatorcontrib>Pereira, Naveen L.</creatorcontrib><creatorcontrib>Behfar, Atta</creatorcontrib><creatorcontrib>Stulak, John M.</creatorcontrib><creatorcontrib>Rodeheffer, Richard J.</creatorcontrib><creatorcontrib>Iyer, Vivek N.</creatorcontrib><title>Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding</title><title>The Journal of heart and lung transplantation</title><addtitle>J Heart Lung Transplant</addtitle><subject>Administration, Intravenous</subject><subject>Aged</subject><subject>Angiogenesis Inhibitors - administration & dosage</subject><subject>Bevacizumab - administration & dosage</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastrointestinal Hemorrhage - drug therapy</subject><subject>Gastrointestinal Hemorrhage - etiology</subject><subject>Heart Failure - therapy</subject><subject>Heart-Assist Devices - adverse effects</subject><subject>Humans</subject><subject>Male</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>1053-2498</issn><issn>1557-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEuLFTEQhYMozjj6D0SydNNtHt1J340gg4-BATe6DpV0ZcwlnR6TdMOIP95c7ujSRahAnVNV5yPkNWc9Z1y9O_Y_EOKWesEE65noGRdPyCUfR91JzvXT9mej7MRwmC7Ii1KOjDEhR_GcXEjB9eldkt83qWbYMa1boRZ3cOHXtoClUCjQtO4Yac0IdcFUqV8zzegzuLrmBxrRV9q8NQe3RcjNVEKpdMY9OOwyRqg40zsoNa8hVSw1JIjURsQ5pLuX5JmHWPDVY70i3z99_Hb9pbv9-vnm-sNt56QStTt4ye1h8HpQOIK20-Tt4JnUzKtTHe3E2dxa82SlVoOTg0Q3caemGQRKeUXenufe5_Xn1q4wSygOY4SELbcRUms1DUqNTTqcpS6vpbSs5j6HBfKD4cycuJujOXM3J-6GCdO4N9ubxw2bXXD-Z_oLugnenwXYcu4BsykuYHKNQ0ZXzbyG_2_4A_SZmS4</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Asleh, Rabea</creator><creator>Albitar, Hasan Ahmad Hasan</creator><creator>Schettle, Sarah D.</creator><creator>Kushwaha, Sudhir S.</creator><creator>Pereira, Naveen L.</creator><creator>Behfar, Atta</creator><creator>Stulak, John M.</creator><creator>Rodeheffer, Richard J.</creator><creator>Iyer, Vivek N.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202005</creationdate><title>Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding</title><author>Asleh, Rabea ; Albitar, Hasan Ahmad Hasan ; Schettle, Sarah D. ; Kushwaha, Sudhir S. ; Pereira, Naveen L. ; Behfar, Atta ; Stulak, John M. ; Rodeheffer, Richard J. ; Iyer, Vivek N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-9f31b94f746e5a7b88fb4f0370f64f035b810de5ad8b3764c343ec81c68da2e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Administration, Intravenous</topic><topic>Aged</topic><topic>Angiogenesis Inhibitors - administration & dosage</topic><topic>Bevacizumab - administration & dosage</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastrointestinal Hemorrhage - drug therapy</topic><topic>Gastrointestinal Hemorrhage - etiology</topic><topic>Heart Failure - therapy</topic><topic>Heart-Assist Devices - adverse effects</topic><topic>Humans</topic><topic>Male</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asleh, Rabea</creatorcontrib><creatorcontrib>Albitar, Hasan Ahmad Hasan</creatorcontrib><creatorcontrib>Schettle, Sarah D.</creatorcontrib><creatorcontrib>Kushwaha, Sudhir S.</creatorcontrib><creatorcontrib>Pereira, Naveen L.</creatorcontrib><creatorcontrib>Behfar, Atta</creatorcontrib><creatorcontrib>Stulak, John M.</creatorcontrib><creatorcontrib>Rodeheffer, Richard J.</creatorcontrib><creatorcontrib>Iyer, Vivek N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of heart and lung transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asleh, Rabea</au><au>Albitar, Hasan Ahmad Hasan</au><au>Schettle, Sarah D.</au><au>Kushwaha, Sudhir S.</au><au>Pereira, Naveen L.</au><au>Behfar, Atta</au><au>Stulak, John M.</au><au>Rodeheffer, Richard J.</au><au>Iyer, Vivek N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding</atitle><jtitle>The Journal of heart and lung transplantation</jtitle><addtitle>J Heart Lung Transplant</addtitle><date>2020-05</date><risdate>2020</risdate><volume>39</volume><issue>5</issue><spage>492</spage><epage>495</epage><pages>492-495</pages><issn>1053-2498</issn><eissn>1557-3117</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32173217</pmid><doi>10.1016/j.healun.2020.02.012</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1053-2498 |
| ispartof | The Journal of heart and lung transplantation, 2020-05, Vol.39 (5), p.492-495 |
| issn | 1053-2498 1557-3117 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2377684665 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Administration, Intravenous Aged Angiogenesis Inhibitors - administration & dosage Bevacizumab - administration & dosage Female Follow-Up Studies Gastrointestinal Hemorrhage - drug therapy Gastrointestinal Hemorrhage - etiology Heart Failure - therapy Heart-Assist Devices - adverse effects Humans Male Retrospective Studies Treatment Outcome |
| title | Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A38%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20bevacizumab%20as%20a%20novel%20treatment%20for%20refractory%20left%20ventricular%20assist%20device-related%20gastrointestinal%20bleeding&rft.jtitle=The%20Journal%20of%20heart%20and%20lung%20transplantation&rft.au=Asleh,%20Rabea&rft.date=2020-05&rft.volume=39&rft.issue=5&rft.spage=492&rft.epage=495&rft.pages=492-495&rft.issn=1053-2498&rft.eissn=1557-3117&rft_id=info:doi/10.1016/j.healun.2020.02.012&rft_dat=%3Cproquest_cross%3E2377684665%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2377684665&rft_id=info:pmid/32173217&rft_els_id=S1053249820314066&rfr_iscdi=true |